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bjectives This study sought to deﬁne the additional effective radiation dose, procedural time, and
ontrast medium needed to obtain fractional ﬂow reserve (FFR) measurements after a diagnostic
oronary angiogram.
ackground The FFR measurements performed at the end of a diagnostic angiogram allow the ob-
aining of functional information that complements the anatomic ﬁndings.
ethods In 200 patients (mean age 66  10 years) undergoing diagnostic coronary angiography,
FR was measured in at least 1 intermediate coronary artery stenosis. Hyperemia was achieved by
ntracoronary (n  180) or intravenous (n  20) adenosine. The radiation dose (mSv), procedural
ime (min), and contrast medium (ml) needed for diagnostic angiography and FFR were recorded.
esults A total of 296 stenoses (1.5  0.7 stenoses per patient) were assessed. The additional
ean radiation dose, procedural time, and contrast medium needed to obtain FFR expressed as a
ercentage of the entire procedure were 30  16% (median 4 mSv, range 2.4 to 6.7 mSv), 26 
3% (median 9 min, range 7 to 13 min), and 31  16% (median 50 ml, range 30 to 90 ml), respec-
ively. The radiation dose and contrast medium during FFR were similar after intravenous and intra-
oronary adenosine, though the procedural time was slightly longer with intravenous adenosine
median 11 min, range 10 to 17 min, p  0.04) than with intracoronary adenosine (median 9 min,
ange 7 to 13 min). When FFR was measured in 3 or more lesions, radiation dose, procedural time,
nd contrast medium increased.
onclusions The additional radiation dose, procedural time, and contrast medium to obtain FFR
easurement are low as compared to other cardiovascular imaging modalities. Therefore, the com-
ination of diagnostic angiography and FFR measurements is warranted to provide simultaneously
natomic and functional information in patients with coronary artery disease. (J Am Coll Cardiol
ntv 2010;3:821–7) © 2010 by the American College of Cardiology Foundation
rom the Cardiovascular Center Aalst, Onze-Lieve-Vrouw Clinic, Aalst, Belgium.Supported by the Meijer Lavino Foundation
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822evascularization of hemodynamically nonsignificant steno-
es does not improve clinical outcome (1). Outcome benefit
s the greatest when demonstrable ischemia is present prior
o revascularization and relieved by the intervention (2).
Nevertheless, a minority of patients undergoing percuta-
eous coronary intervention (PCI) have not had a nonin-
asive stress test prior to catheterization (3), even in the case
f stable coronary artery disease and elective PCI (4). When
evascularization is based mainly on angiographic guidance,
t is unavoidable that a number of hemodynamically non-
ignificant stenoses will be revascularized, and that a num-
er of stenoses deemed hemodynamically nonsignificant will
e deferred inappropriately (5).
Because the combination of an anatomic and functional
tandard appears to be an appropriate decision-maker for
evascularization (6), but the necessary functional informa-
ion is often lacking or inconclusive, fractional flow reserve
FFR) measurements are often performed to complement a
iagnostic coronary angiography. Concern has been raised
bout the radiation dose and amount of contrast medium
ssociated with cardiac imaging. There is also a perception
hat FFR might add an unreasonable amount of time,
ontrast, and radiation exposure to a diagnostic study.
The purpose of this study was
to investigate the additional ef-
fective radiation dose, amount
of contrast medium, and time
needed for FFR measurements
in patients undergoing diagnos-
tic coronary angiography.
ethods
tudy population. Between January 2009 and September
009, 803 patients underwent FFR measurements in Car-
iovascular Center Aalst. In 438 patients, FFR was per-
ormed during PCI, and in 47 patients, pressure measure-
ents were obtained in renal artery stenoses and were
xcluded. In 316 patients, FFR was obtained at the end of
diagnostic procedure. Of those, 116 were excluded because
adiation dose was not recorded properly. Finally, 200
atients were prospectively included in the present registry.
n all of them, FFR measurements were performed at the
nd of a diagnostic angiogram to determine the appropriate
reatment strategy. The exact dose of radiation, the time,
nd the amount of contrast medium were carefully recorded.
o patients were excluded because of an unfavorable
natomy.
tudy protocol. Biplane left ventricular and coronary an-
iography were obtained in all patients. The number and
ype of projections was left to the operator’s discretion. For
ll the coronary artery stenoses assessed by FFR, quantita-
ive coronary angiography analysis was performed offline in
bbreviations
nd Acronyms
FR  fractional flow
eserve
CI  percutaneous
oronary interventionorthogonal projections using an automated contour de- bection algorithm (ACOM, PC version 5.01, Siemens
edical Systems, Inc., Cary, North Carolina).
FR assessment. Fractional flow reserve was measured as
reviously described (7). Briefly, after intravenous adminis-
ration of heparin (100 U/kg of body weight), and intra-
oronary administration of isosorbide dinitrate (200 g), a
ressure monitoring guidewire (Certus PressureWire, Radi
edical Systems, Uppsala, Sweden) was calibrated and
ntroduced in the guiding catheter. Before advancing the
ressure sensor distal to the stenosis, the pressures recorded
y the sensor and by the guiding catheter were equalized.
or ostial lesions, equalization of the pressures was obtained
n the aortic root, outside the diseased ostium of the vessel.
hen, the pressure wire was advanced distal to the coronary
rtery stenosis. In every case, the position of the wire was
lmed with the administration of contrast medium to
nsure the correct placement of the wire.
Hyperemia was obtained after administration of intrave-
ous (140 g/kg/min, n  20) or intracoronary adenosine
bolus injection of 50 g for both left and right coronary
rtery, n  180). Fractional flow reserve was defined as the
atio of the mean arterial pressure distal to the stenosis
easured by the pressure wire sensor to the mean aortic
ressure at the tip of the guiding catheter during hyperemia.
hen intracoronary adenosine was used to induce hyper-
mia, FFR was measured twice and the average FFR value
f both measurements was taken. After FFR assessment, the
ressure sensor was pulled back at the tip of the guiding
atheter and both pressures (guiding and wire) were care-
ully checked. In case of uneven pressures, equalization of
he pressures and FFR were repeated. If the pressure ratio
as equal to 1, the pressure wire was removed out of the
uiding catheter and a final control coronary angiogram of
he studied vessel was performed.
ffective radiation dose, procedure time, and contrast
edium. The effective radiation dose (mSv), the procedure
ime (min), and contrast medium (ml) were recorded
eparately for the diagnostic angiography and for the ma-
ipulations related to the FFR measurements. For the
iagnostic coronary angiogram, all parameters were re-
orded between the anesthesia of the skin and the moment
he operator decided to obtain FFR measurements. For the
FR measurements, all parameters were recorded from the
oment the operator decided to obtain FFR measurements
ntil the end of the final control coronary angiogram just
fter having obtained the FFR values and removing the
ressure monitoring guidewire. This includes the exchange
f a diagnostic catheter for a 6-F guide catheter and the
lacement of a Y-connector between the manifold and the
uide catheter. The operators were blinded to the radiation,
ime, and contrast values measured before and during FFR
ssessment. For most patients, the operator was even
linded to the fact that these measurements were recorded.
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823The “absorbed radiation dose” in both biplane X-ray
ystems used (Siemens AXIOM Artis 2004 and Bicor) was
utomatically calculated in mGy/cm2. The absorbed dose
orresponds to the energy absorbed per unit of body mass as
result of exposure to ionizing radiation (8). However, to
stimate the probability of adverse biological effects induced
y the radiation, the “effective dose” was also calculated
mSv). For the calculation of the effective dose, either the
onte Carlo–based computer simulation as described by
ervomaa et al. (9) or the tables of conversion factors as
efined by the National Radiological Protection Board (10)
an be used. They both implement a special conversion
actor as defined by the field size, filtration, tube potential,
eometry, and type of filming (fluoroscopy or cineradiogra-
hy) to convert absorbed into effective dose (11,12). In our
atheterization laboratory, additional copper filtration is
resent in both X-ray equipments and the specific conver-
ion factor was previously calculated as of 0.203 (12). In our
egistry, to convert the absorbed dose into the effective dose
f radiation, the conversion factor was multiplied with the
bsorbed dose as previously described (12).
tatistical analysis. SPSS version 16.0 (SPSS, Inc., Chi-
ago, Illinois) was used for the statistical analysis of the data.
ontinuous variables are expressed as mean  SD. Paired
nd unpaired Student t tests were used to compare normally
istributed variables. Wilcoxon and Mann-Whitney non-
arametric tests were used for the comparison of the
on-Gaussian distributed variables. One-way analysis of
ariance and the parametric Bonferroni post hoc test or
ruskal-Wallis and the nonparametric Dunn post hoc test
ere used for the comparison of radiation, time, and
ontrast during 1-, 2-, and 3-vessel (or more) FFR mea-
urements. Categorical variables are expressed as frequencies
nd percentages. Radiation, time, and contrast during FFR
btained after intracoronary adenosine administration were
ompared with radiation, time, and contrast during diag-
ostic coronary angiography. The same parameters during
Table 1. Clinical Characteristics, Treatment, and Lab
Characteristics
All-Study Population
(n  200)
Intra
Age, yrs 66 10
Men/women, % 76/24
BMI, kg/m2 27 4
LAD/LCx/RCA/Other* 51/22/20/7
SA/UA/SI/Other† 40/6/7/47
Previous MI, % 23
Previous PCI, % 48
Previous CABG, % 6
The p values indicate the statistical difference between the intracoro
reserve. †Clinical indication for catheterization.
BMI  body mass index; CABG  coronary artery bypass graft
MI  myocardial infarction; PCI  percutaneous coronary interventiUA unstable angina.ultilesion FFR measurements were compared with
-lesion FFR measurements. Radiation, time, and contrast
alues after intracoronary adenosine administration were
lso compared with radiation, time, and contrast after
ntravenous adenosine infusion. The p values 0.05 were
onsidered statistically significant.
esults
aseline characteristics. The data of 296 stenoses assessed
y FFR after a diagnostic coronary angiography in 200
onsecutive patients (1.5 0.7 per patient) were included in
he final analysis. Demographic and clinical data of the
atients are shown in Table 1. The majority of the study
opulation were men presenting with stable angina. Almost
ne-half of the patients had a PCI in the past and
ne-fourth had a previous history of myocardial infarction.
ean left ventricular end-diastolic pressure and ejection
raction were 15  6 mm Hg and 68  17%, respectively
Table 2). The mean percentage diameter stenosis by
uantitative coronary angiography and mean FFR values
ere 42 14 % and 0.84 0.09, respectively (Table 2). No
omplication was observed in relation to the FFR
easurements.
otal values of radiation, time, and contrast. The median
alues of radiation, time, and contrast needed to measure
FR were lower than the corresponding values needed for
iagnostic left heart catheterization and coronary angiogram
Fig. 1). On average, an additional median radiation of 4
range 2.4 to 6.7) mSv (30  16% of the total radiation
eeded for diagnostic catheterization), an additional median
ime of 9 (range 7 to 13) min (26  13% of the total time
eeded for diagnostic catheterization), and an additional
edian contrast of 50 (range 30 to 90) ml (31 16% of the
otal contrast needed for diagnostic catheterization) were
equired to obtain FFR measurements. Expressed per lesion
easured, the corresponding median values of additional
ry Data of the Study Population
ry Adenosine
180)
Intravenous Adenosine
(n  20) p Value
 10 68 12 0.56
4 70/30 0.58
 4 26 4 0.48
3/20/7 64/12/12/12 0.43
/7/48 33/7/0/60 0.60
23 13 0.52
49 33 0.29
6 13 0.24
d intravenous adenosine groups. *Vessel assessed by fractional flow
 left anterior descending artery; LCx  left circumflex artery;
 right coronary artery; SA  stable angina; SI  silent ischemia;orato
corona
(n 
66
76/2
27
50/2
40/5
nary an
ing; LAD
on; RCA
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824adiation, time, and contrast are 2.8 (range 1.7 to 4.5) mSv,
(range 5 to 9) min, and 35 (range 25 to 50) ml (Fig. 2).
he additional radiation, time, and contrast needed for
FR, as expressed per lesion measured, correspond to 22%,
0%, and 23% radiation, time, and contrast on top of the
iagnostic left heart catheterization (Fig. 2).
ffect of number of vessels measured. The FFR measure-
ents were performed in 1 lesion in 126 patients (63%), in
lesions in 53 patients (26%), and in 3 or more lesions in 21
atients (11%). Total radiation, time, and contrast were
imilar when FFR was measured in 1 or 2 lesions. In
ontrast, total radiation, time, and contrast increased
lightly when 3 or more lesions were measured by FFR
median 14 [range 9 to 21] mSv vs. 17 [range 15 to 27] mSv,
edian 40 [range 30 to 52] min vs. 49 [range 40 to 61.5] min,
nd median 175 [range 145 to 219] ml vs. 225 [range 195 to
54] ml for 1 and 3 vessels, respectively; p  0.05) (Fig. 3).
he radiation, time, and contrast remained unchanged
uring coronary angiogram, and thus the increase of total
adiation, time, and contrast when 3 or more lesions were
easured by FFR is attributed to a slight increase of
adiation, time, and contrast during FFR measurements
Table 2. Hemodynamic, Angiographic, and Functiona
All-Study Population
(n  200)
Intraco
LVEF, % 68 17
LVEDP, mm Hg 15 6
HR, beats/min 70 12
DS, % 42 14
MLD, mm 1.7 0.5
RD, mm 2.9 0.7
FFR 0.84 0.09 0
The p values indicate the statistical difference between the intracoron
DS diameter of stenosis; FFR fractional flow reserve; HR hear
ejection fraction; MLDminimum lumen diameter; RD reference d
Figure 1. Effective Radiation Dose, Procedural Time, and Contrast Medium
Bar graph showing the median values of effective radiation dose (A), procedu
nary angiogram, and fractional ﬂow reserve (FFR) (expressed per vessel) after i
the diagnostic coronary angiogram and FFR measurements.median 2.8 [range 1.7 to 4.5] mSv vs. 6.6 [range 4.3 to 8.4]
Sv, median 7 [range 5 to 9] min vs. 15 [range 12 to 17]
in, and median 35 [range 25 to 50] ml vs. 90 [range 52.5
o 108] ml for 1 and 3 vessels, respectively; p  0.05]).
ntracoronary versus intravenous adenosine. Total radiation
nd contrast did not vary according to the route of admin-
stration of adenosine. Yet, in patients in whom hyperemia
as induced by intravenous adenosine, the time needed
o obtain FFR measurements was slightly longer (Table 3,
ig. 4).
iscussion
he main finding of the present study is that the additional
adiation, time, and contrast required to define the hemo-
ynamic significance of coronary artery stenoses using FFR
s limited as compared to other cardiac imaging modalities.
he additional functional information provided by FFR on
op of the angiographic anatomic information for a single
oronary artery stenosis can be reliably obtained at the cost
f an extra 2.8 mSv of effective radiation dose, 7 min of
rocedural time, and 35 ml of contrast medium.
surements
Adenosine
80)
Intravenous Adenosine
(n  20) p Value
17 71 13 0.49
7 17 5 0.39
12 69 11 0.93
13 40 16 0.39
0.5 1.6 0.5 0.71
0.7 2.7 0.6 0.95
0.09 0.84 0.07 0.98
intravenous adenosine groups.
VEDP left ventricular end-diastolic pressure; LVEF left ventricular
.
e (B), and contrast medium (C) during the total procedure, diagnostic coro-
ronary adenosine administration. The p values refer to differences betweenl Mea
ronary
(n  1
68
15
70
42
1.7
2.9
.84
ary and
t rate; Lral tim
ntraco
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825FR as a surrogate for noninvasive testing. The majority of
atients undergoing PCI never underwent any kind of
oninvasive stress testing (3,4). Although the limitation
f angiography in assessing lesion severity is widely ac-
nowledged, most decisions about revascularization are
aken merely on the basis of the angiogram. Pressure-
erived FFR provides the same information as myocardial
erfusion imaging except that: 1) FFR is more accurate to
efining the severity of angiographic intermediate stenoses
hat induce ischemia; 2) FFR has a better spatial resolu-
ion; and 3) most importantly, it is available in the
atheterization laboratory, the very place where the treat-
ent can be applied (7). Therefore, the combination of
iagnostic angiography and FFR measurements provides
Figure 2. Per-Lesion Effective Radiation, Procedural Time,
and Contrast Medium
Bar graph showing the median values of the additional radiation, proce-
dural time, and contrast medium needed for fractional ﬂow reserve mea-
surements (as expressed per lesion) after intracoronary adenosine.
Abbreviation as in Figure 1.
Figure 3. Effective Radiation Dose, Procedural Time, and Contrast Medium
Bar graph showing the median values the additional total effective radiation (
FFR in 1, 2, or 3 stenoses using intracoronary adenosine. Abbreviation as in Figure 1he unique opportunity to obtain anatomic and functional
nformation at the same place and at the same time.
ffective dose of radiation and cardiac imaging. Concerns
ave been raised about the dose of ionizing radiation related
o imaging modalities (8,13,14). Deterministic effects such
s skin erythema, epilation, and cataract formation are
ependent on the radiation dose. Also, exposure to low-
ose ionizing radiation confers a definite, albeit low, long-
erm risk of cancer and leukemia (15–19). In a recent
ross-sectional international multicenter study of estimated
adiation dose in 1,965 patients undergoing coronary com-
uted tomography angiography (18), the typical effective
adiation doses ranged from 4.5 to 29 mSv (average 12
Sv). Similarly, myocardial perfusion imaging is typically
ssociated with an average effective radiation dose of 15.6
Sv (13). Thus, as shown in the present study, the total
ffective radiation dose generated by the combination of left
entricular and coronary angiography and FFR (approxi-
ately 16 mSv) is similar to either myocardial perfusion
maging or computed tomography coronary angiography.
ultivessel Disease
cedural time (B), and contrast medium plots (C) needed to measure
Table 3. Median Values With Their IQR of Radiation, Time, and Contrast
After Administration of Intracoronary and Intravenous Adenosine
Intracoronary Adenosine
(n  180)
Intravenous Adenosine
(n  20) p Value
Radiation, mSv
CA 11 (7–16) 9 (4.5–13) 0.18
FFR 4 (2.4–6.7) 3.9 (1.6–6.7) 0.36
Time, min
CA 30 (22–42) 28 (20–39) 0.19
FFR 9 (7–13) 11 (10–17) 0.04
Contrast medium, ml
CA 130 (105–160) 135 (94–176) 0.78
FFR 50 (30–90) 38 (24–60) 0.08
CA coronary angiography; IQR interquartile range; other abbreviation as in Table 2.in M
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826he diagnostic workup of patients with known or suspected
oronary artery disease often comprises several imaging
rocedures exposing them to substantial doses of ionizing
adiations (17).
uration of FFR measurements. The additional time needed
o obtain FFR measurements is a reason of concern in many
usy catheterization laboratories. This time is critically
ependent on logistic factors. If the interface has to be
witched on, connected, and configured each time an FFR
easurement is contemplated, this additional time burden
ill be taken as a reason not to perform the measurement.
he same holds for the preparation of the hyperemic agent.
n the present study, the decision to measure FFR was taken
fter the diagnostic angiogram and was therefore always
unplanned.” The stopwatch was set on the request of the
uiding catheter and was stopped after the control coronary
ngiogram just after the removal of the pressure wire from
he coronary tree. On average, the time needed to obtain
FR measurements at the end of a diagnostic angiogram
as 7 min in 1 coronary artery and 15 min in 3 or more
oronary arteries. This time is obviously much shorter than
hat needed to obtain a myocardial perfusion imaging, a
tress echocardiogram, or any other form of functional
maging. This prolongation in 3-vessel disease patients was
ainly related to the fact that the guide catheter had to be
xchanged. It is technically possible to measure FFR with a
iagnostic catheter (20). In our experience, however, wire
anipulations are more difficult than through a guide
atheter. In addition, when PCI is needed, an additional
atheter exchange is necessary. In the present study, a
odest but significant prolongation (by 2 min) of the time
eeded to obtain the FFR measurement was observed when
denosine was given intravenously. This is essentially related
o logistic factors. In this respect, it is important to empha-
ize that in all cases, intravenous adenosine was given via a
ransfemoral line that was installed while the nurse was
Figure 4. Radiation, Procedural Time, and Contrast: Intracoronary Versus I
Bar graph showing the median values of effective radiation dose (A), procedu
tration of intracoronary (IC) or intravenous (IV) adenosine. Abbreviation as in Freparing the intravenous infusion. aontrast medium and FFR. The risk of acute renal failure
fter administration of contrast medium is proportional to
he amount of contrast medium and to the pre-existing
lomerular filtration rate (21). Typically, the amount of
ontrast medium given for coronary computed tomography
ngiography is approximately 100 ml. The present study
ndicates that even when multiple lesions are assessed by
FR (3), the extra amount of contrast medium required is
elatively limited (50 ml). Implementing FFR for all
ubious stenoses, the actual risk of acute kidney injury
hould diminish rather than expand, because almost one-
hird of angiographically “significant” stenoses appear to be
emodynamically nonsignificant (22). Future prospective
rials should definitely answer this question, although, in
ultivessel PCI, the amount of contrast medium was
maller when the need for revascularization was guided by
FR than when it was guided solely on the basis of the
ngiogram (23).
tudy limitations. The present data were obtained in a
enter performing more than 1,000 FFR per year. More
han one-third of these measurements are obtained in the
etting of diagnostic angiography when a doubt about the
ptimal treatment persists at the end of the angiogram.
hese results may not necessarily be generalized to labora-
ories or operators that only infrequently perform FFR.
linical implications. To avoid unnecessary catheterization
nd to guide the treatment, functional testing should be
btained in patients with suspected or known coronary
rtery disease before considering catheterization. Yet, real-
orld data (3,4) indicate that only a minority of patients
ndergo noninvasive imaging prior to angiography. Mea-
uring FFR at the end of a diagnostic angiogram is an
lternative way to obtain the same information (6). The low
dditional effective radiation dose, procedural time, and
olume of contrast medium required for FFR underscore its
pplicability and safety. These findings further support an
nous Adenosine
e (B), and contrast medium (C) during FFR measurements after the adminis-
1.ntrave
ral timll-in-one approach in patients with coronary artery disease
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827nd equivocal coronary artery stenoses, that is, obtaining a
omplete diagnostic anatomic and functional workup and
eciding the appropriateness of revascularization or not at
he same place and at the same time.
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